{"id":"https://openalex.org/W2742813652","doi":"https://doi.org/10.1128/aac.00988-17","title":"Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis","display_name":"Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis","publication_year":2017,"publication_date":"2017-08-08","ids":{"openalex":"https://openalex.org/W2742813652","doi":"https://doi.org/10.1128/aac.00988-17","mag":"2742813652","pmid":"https://pubmed.ncbi.nlm.nih.gov/28784670","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5610479"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00988-17","doi":"https://doi.org/10.1128/aac.00988-17","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00988-17","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5610479","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039255585","display_name":"Timothy J. Bensman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Bensman","raw_affiliation_strings":["Biomedical Simulations Resource, Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Simulations Resource, Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101519484","display_name":"Joshua Wang","orcid":"https://orcid.org/0009-0003-4519-2958","observed_orcids":["https://orcid.org/0009-0003-4519-2958"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Wang","raw_affiliation_strings":["Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028637588","display_name":"Jordanna G. Jayne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jordanna Jayne","raw_affiliation_strings":["Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052670810","display_name":"Lynn Fukushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Fukushima","raw_affiliation_strings":["Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066514279","display_name":"Adupa P. Rao","orcid":"https://orcid.org/0000-0002-0220-7131","observed_orcids":["https://orcid.org/0000-0002-0220-7131"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adupa P. Rao","raw_affiliation_strings":["Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027239674","display_name":"David Z. D\u2019Argenio","orcid":"https://orcid.org/0000-0003-3658-7088","observed_orcids":["https://orcid.org/0000-0003-3658-7088"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Z. D'Argenio","raw_affiliation_strings":["Biomedical Simulations Resource, Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Simulations Resource, Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048749857","display_name":"Paul M. Beringer","orcid":"https://orcid.org/0000-0002-3744-3310","observed_orcids":["https://orcid.org/0000-0002-3744-3310"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul M. Beringer","raw_affiliation_strings":["Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1174212"],"apc_list":null,"apc_paid":null,"fwci":3.4352,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.92120099,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"61","issue":"10","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftazidime-avibactam","display_name":"ceftazidime-avibactam","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pulmonary-exacerbations","display_name":"pulmonary exacerbations","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/probability-of-target-attainment","display_name":"probability of target attainment","score":0.7599999904632568},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.8119999766349792},{"id":"https://openalex.org/keywords/avibactam","display_name":"avibactam","score":0.9860000014305115},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.7940000295639038},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5329999923706055},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.7739999890327454},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C2775933652","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Ceftazidime/avibactam","level":5,"score":0.9138838052749634},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7735947370529175},{"id":"https://openalex.org/C2777406300","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Avibactam","level":5,"score":0.7419202327728271},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.6499510407447815},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6044098734855652},{"id":"https://openalex.org/C176674119","wikidata":"https://www.wikidata.org/wiki/Q11582","display_name":"Liter","level":2,"score":0.5444186925888062},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5349506139755249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5140506029129028},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.5122989416122437},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5029401183128357},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4656931161880493},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32328081130981445},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.3085474371910095},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22216129302978516},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065093","descriptor_name":"beta-Lactamase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D065093","descriptor_name":"beta-Lactamase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.00988-17","doi":"https://doi.org/10.1128/aac.00988-17","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00988-17","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5610479","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5610479","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:28784670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28784670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase IV"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5610479","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5610479","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6218757975","display_name":"Biomedical Simulations Resource (BMSR)","funder_award_id":"P41EB001978","funder_id":"https://openalex.org/F4320337363","funder_display_name":"National Institute of Biomedical Imaging and Bioengineering"},{"id":"https://openalex.org/G9000887743","display_name":"Southern California Clinical and Translational Science Institute","funder_award_id":"UL1TR001855","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"},{"id":"https://openalex.org/F4320333571","display_name":"Alfred E. Mann Institute for Biomedical Engineering, University of Southern California","ror":null},{"id":"https://openalex.org/F4320337363","display_name":"National Institute of Biomedical Imaging and Bioengineering","ror":"https://ror.org/00372qc85"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1583606950","https://openalex.org/W1989525615","https://openalex.org/W1999435300","https://openalex.org/W2025774694","https://openalex.org/W2033010355","https://openalex.org/W2041756676","https://openalex.org/W2046055447","https://openalex.org/W2049789253","https://openalex.org/W2052417907","https://openalex.org/W2056317617","https://openalex.org/W2060495363","https://openalex.org/W2069923587","https://openalex.org/W2079691262","https://openalex.org/W2098057508","https://openalex.org/W2107395970","https://openalex.org/W2113717321","https://openalex.org/W2114121673","https://openalex.org/W2116089057","https://openalex.org/W2118354144","https://openalex.org/W2119322789","https://openalex.org/W2121416492","https://openalex.org/W2124369982","https://openalex.org/W2143843692","https://openalex.org/W2144947606","https://openalex.org/W2150714701","https://openalex.org/W2151739450","https://openalex.org/W2154381036","https://openalex.org/W2155745552","https://openalex.org/W2157195518","https://openalex.org/W2169221816","https://openalex.org/W2171464982","https://openalex.org/W2262202809","https://openalex.org/W2271159954","https://openalex.org/W2515632632"],"related_works":["https://openalex.org/W2515632632","https://openalex.org/W2345560975","https://openalex.org/W4288425134","https://openalex.org/W6976944636","https://openalex.org/W2051481380","https://openalex.org/W2104659136","https://openalex.org/W2150714701","https://openalex.org/W2015039953","https://openalex.org/W4402963548","https://openalex.org/W2345213370"],"abstract_inverted_index":{"ABSTRACT":[0],"Acute":[1],"pulmonary":[2],"exacerbations":[3],"(APE)":[4],"involving":[5],"Pseudomonas":[6],"aeruginosa":[7],"are":[8],"associated":[9],"with":[10,300],"increased":[11],"morbidity":[12],"and":[13,67,154,189,201,228,304],"mortality":[14],"in":[15,32,54,82,298],"cystic":[16],"fibrosis":[17],"(CF)":[18],"patients.":[19,56],"Drug":[20],"resistance":[21],"is":[22],"a":[23,130,164,173,260,278],"significant":[24],"challenge":[25],"to":[26,61,72,195,252],"treatment.":[27],"Ceftazidime-avibactam":[28],"(CZA)":[29],"demonstrates":[30],"excellent":[31],"vitro":[33],"activity":[34],"against":[35],"isolates":[36],"recovered":[37],"from":[38],"CF":[39,55,85],"patients,":[40],"including":[41],"drug-resistant":[42],"strains.":[43],"Altered":[44],"pharmacokinetics":[45],"(PK)":[46],"of":[47,65,80,91,117,125,129,159,163,211,230,267,271,277,296,302,311],"several":[48],"beta-lactam":[49],"antibiotics":[50],"have":[51],"been":[52,319],"reported":[53],"Therefore,":[57],"this":[58],"study":[59,317],"sought":[60],"characterize":[62],"the":[63,74,106,115,126,134,139,160,168,308],"PK":[64,79],"CZA":[66,81,190,258,297,312],"perform":[68],"target":[69,118,123,157],"attainment":[70,119],"analyses":[71],"determine":[73],"optimal":[75,309],"treatment":[76,279],"regimen.":[77],"The":[78,209,274],"12":[83],"adult":[84],"patients":[86],"administered":[87],"3":[88],"intravenous":[89],"doses":[90],"2.5":[92],"g":[93],"every":[94],"8":[95],"h":[96,100],"infused":[97],"over":[98],"2":[99],"were":[101,193,203,249],"determined.":[102],"Population":[103],"modeling":[104],"utilized":[105],"maximum":[107],"likelihood":[108,276],"expectation":[109],"method.":[110],"Monte":[111],"Carlo":[112],"simulations":[113],"determined":[114],"probability":[116],"(PTA).":[120],"An":[121],"exposure":[122,156],"consisting":[124,158],"cumulative":[127,161,197],"percentage":[128,162],"24-h":[131,165],"period":[132,166],"that":[133,167],"free":[135,169],"drug":[136,170],"concentration":[137,171,176],"exceeds":[138,172],"MIC":[140,191],"under":[141,323],"steady-state":[142],"pharmacokinetic":[143],"conditions":[144],"(":[145,177,232,262],"fT":[146,178,263],">MIC":[147,264],")":[148,181],"was":[149,182,281,287],"evaluated":[150,183],"for":[151,184,255,269,283,289,313],"ceftazidime":[152],"(CAZ),":[153],"an":[155],"1-mg/liter":[174],"threshold":[175],">1":[179],"mg/liter":[180],"avibactam":[185],"(AVI).":[186],"Published":[187],"CAZ":[188,200,216,235,303],"distributions":[192],"incorporated":[194],"evaluate":[196],"response":[198,280],"probabilities.":[199],"AVI":[202,222,242],"best":[204],"described":[205],"by":[206],"one-compartment":[207],"models.":[208],"values":[210,254],"total":[212],"body":[213],"clearance":[214],"(CL;":[215],"CL,":[217,223],"7.53":[218],"\u00b1":[219,225,239,246],"1.28":[220],"liters/h;":[221],"12.30":[224],"1.96":[226],"liters/h)":[227],"volume":[229],"distribution":[231],"V":[233,236,243],";":[234],",":[237,244,265],"18.80":[238],"6.54":[240],"liters;":[241],"25.30":[245],"4.43":[247],"liters)":[248],"broadly":[250],"similar":[251],"published":[253],"healthy":[256],"adults.":[257],"achieved":[259],"PTA":[261],"50%)":[266],">0.9":[268],"MICs":[270],"\u226416":[272],"mg/liter.":[273],"overall":[275],"0.82":[282],"CZA,":[284],"whereas":[285],"it":[286],"0.42":[288],"CAZ.":[290],"These":[291],"data":[292],"demonstrate":[293],"improved":[294],"pharmacodynamics":[295],"comparison":[299],"those":[301],"provide":[305],"guidance":[306],"on":[307],"dosing":[310],"future":[314],"studies.":[315],"(This":[316],"has":[318],"registered":[320],"at":[321],"ClinicalTrials.gov":[322],"registration":[324],"no.":[325],"NCT02504827.)":[326]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-08-17T00:00:00"}